T
Terumitsu Tanaka
Researcher at Takeda Pharmaceutical Company
Publications - 16
Citations - 742
Terumitsu Tanaka is an academic researcher from Takeda Pharmaceutical Company. The author has contributed to research in topics: Pericardial fluid & Myocardial infarction. The author has an hindex of 10, co-authored 16 publications receiving 715 citations. Previous affiliations of Terumitsu Tanaka include Kyoto University.
Papers
More filters
Journal ArticleDOI
Aortic Arch Reconstruction by Transluminally Placed Endovascular Branched Stent Graft
Kanji Inoue,Hiroaki Hosokawa,Tomoyuki Iwase,Mitsuru Sato,Yuki Yoshida,Katsuya Ueno,Akiyoshi Tsubokawa,Terumitsu Tanaka,Shunichi Tamaki,Takahiko Suzuki +9 more
TL;DR: Careful, longer follow-up and further extensive clinical trials are awaited toward establishing this technique as a recommendable alternative to surgical treatment of thoracic aortic aneurysms.
Journal ArticleDOI
Elevated Basic Fibroblast Growth Factor in Pericardial Fluid of Patients With Unstable Angina
Masatoshi Fujita,Masaki Ikemoto,Masamichi Kishishita,Hideo Otani,Ryuji Nohara,Terumitsu Tanaka,Shunichi Tamaki,Ario Yamazato,Shigetake Sasayama +8 more
TL;DR: This finding provides new evidence that bFGF plays an important role in mediating collateral growth in humans.
Journal ArticleDOI
Clinical endovascular placement of branched graft for type B aortic dissection
Kanji Inoue,Mitsuru Sato,Tomoyuki Iwase,Yuki Yoshida,Terumitsu Tanaka,Shunichi Tamaki,Ario Yamazato +6 more
Journal ArticleDOI
Marked Elevation of Brain Natriuretic Peptide Levels in Pericardial Fluid Is Closely Associated With Left Ventricular Dysfunction
Terumitsu Tanaka,Koji Hasegawa,Masatoshi Fujita,Shunichi Tamaki,Ario Yamazato,Yasuki Kihara,Ryuji Nohara,Shigetake Sasayama +7 more
TL;DR: BNP may be secreted from the heart into the pericardial space in response to left ventricular dysfunction, and it may have a pathophysiologic role in heart failure as an autocrine/paracrine factor.
Journal ArticleDOI
Improvement of exercise capacity by sarpogrelate as a result of augmented collateral circulation in patients with effort angina
Terumitsu Tanaka,Masatoshi Fujita,Izuru Nakae,Shunichi Tamaki,Koji Hasegawa,Yasuki Kihara,Ryuji Nohara,Shigetake Sasayama +7 more
TL;DR: Sarpog Relate augments flow reserve of the collateral circulation and improves exercise capacity in anginal patients with well-developed collaterals, indicating that a serotonin blocker, sarpogrelate, is useful not only as an antiplatelet drugs, but as anAntianginal drug.